See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2020_RespireRx_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000849636')"} |
Graph
Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,328 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 7,490,147 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,137,175 |
| 9 | ResearchAndDevelopmentExpense | 599,329 |
| 10 | remainder_Expenses | 404,661 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 26,132 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,328 |
| 1 | Liabilities | 7,490,147 |
| 2 | Expenses | 2,141,165 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -7,444,819 |
| 5 | NetIncome | -2,115,033 |
| 6 | ComprehensiveNetIncome | -2,115,033 |
| 7 | BaseVar | 4,851,386 |
| 8 | EconomicCapitalRatio | -3.96 |
Edgar->Model Mapping
Feature Distribution
Change over Time
